|
|
It is therefore not possible for companies outside the EU to
To support your complete
drug development program in
the world‘s largest pharma-
ceutical market we offer you
|
|
|
|
 Conduct any clinical drug or medical device trials without having
 established a legal or an authorized representative in the EU
Submit Product/Biological License Applications from a country
outside the EU
Submit Orphan Drug Designation Applications from outside the EU
Solutions making it unneccesary for you to establish and maintain
your own subsidiary in the European Union.
Knowledge derived from over 60 projects with more than 40 com-
panies from the USA and Asia.
Employees who have a strong background in practical clinical
development and who know your needs.
Ready to use agreements which have been permanently improved
during our projects starting from the year when the Clinical Trials
Directive has been implemented.
|
